Although SENP3 has been implicated in cancer and metabolic disease through its deSUMOylation of substrates such as β-catenin, YAP1 and CTH [17–22], its potential role in atherosclerosis and VSMC phenotypic modulation has not been examined. The gene discussed is SENP3; the disease is atherosclerosis.